Immunomodulatory neural stem cells for brain tumour therapy

Bibliography

• SNYDER EY, DEITCHER DL, WALSH C et al.: Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell (1992) 68(1):33-51.
   PubMed Web of Science ®Google Scholar
• PARK KI, TENG YD, SNYDER EY: The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue. Nat. Biotechnol. (2002) 20(11):1111-1117.
   PubMed Web of Science ®Google Scholar
• FLAX JD, AURORA S, YANG C et al.: Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. Nat. Biotechnol. (1998) 16(11):1033-1039.
   PubMed Web of Science ®Google Scholar
• OUREDNIK J, OUREDNIK V, LYNCH WP, SCHACHNER M, SNYDER EY: Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat. Biotechnol. (2002) 20(11):1103-1110.
   PubMed Web of Science ®Google Scholar
• WAGNER J, AKERUD P, CASTRO DS et al.: Induction of a midbrain dopaminergic phenotype in Nurr1-overexpressing neural stem cells by Type 1 astrocytes. Nat. Biotechnol. (1999) 17(7):653-659.
   PubMed Web of Science ®Google Scholar
• PARK KI, OUREDNIK J, OUREDNIK V et al.: Global gene and cell replacement strategies via stem cells. Gene Ther. (2002) 9(10):613-624.
   PubMed Web of Science ®Google Scholar
• KABOS P, EHTESHAM M, BLACK KL, YU JS: Neural stem cells as delivery vehicles. Expert Opin. Biol. Ther. (2003) 3(5):759-770.
   PubMed Web of Science ®Google Scholar
• EHTESHAM M, KABOS P, KABOSOVA A et al.: The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma. Cancer Res. (2002) 62(20):5657-5663.
   PubMed Web of Science ®Google Scholar
• EHTESHAM M, KABOS P, GUTIERREZ MA et al.: Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res. (2002) 62(24):7170-7174.
   PubMed Web of Science ®Google Scholar
• ABOODY KS, BROWN A, RAINOV NG et al.: Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc. Natl. Acad. Sci. USA (2000) 97(23):12846-12851.
   PubMed Web of Science ®Google Scholar
• ARSENIJEVIC Y, VILLEMURE JG, BRUNET JF et al.: Isolation of multipotent neural precursors residing in the cortex of the adult human brain. Exp. Neurol. (2001) 170(1):48-62.
   PubMed Web of Science ®Google Scholar
• YUAN X, HU J, BELLADONNA ML, BLACK KL, YU JS: Interleukin-23-Expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma. Cancer Res. (2006) 66(5):2630-2638.
   PubMed Web of Science ®Google Scholar
• WU M, DAS A, TAN Y et al.: Induction of apoptosis in glioma cell lines by TRAIL/Apo-2l. J. Neurosci. Res. (2000) 61(4):464-470.
   PubMed Web of Science ®Google Scholar
• TANG Y, SHAH K, MESSERLI SM et al.: In vivo tracking of neural progenitor cell migration to glioblastomas. Hum. Gene Ther. (2003) 14(13):1247-1254.
   PubMed Web of Science ®Google Scholar
• IMITOLA J, RADDASSI K, PARK KI et al.: Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc. Natl. Acad. Sci. USA (2004) 101(52):18117-18122.
   PubMed Web of Science ®Google Scholar
• EHTESHAM M, YUAN X, KABOS P et al.: Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4. Neoplasia (2004) 6(3):287-293.
   PubMed Web of Science ®Google Scholar
• BENEDETTI S, PIROLA B, POLLO B et al.: Gene therapy of experimental brain tumors using neural progenitor cells. Nat. Med. (2000) 6(4):447-450.
   Google Scholar
• NAKAMIZO A, MARINI F, AMANO T et al.: Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res. (2005) 65(8):3307-3318.
   PubMed Web of Science ®Google Scholar
• EHTESHAM M, SAMOTO K, KABOS P et al.: Treatment of intracranial glioma with in situ interferon-gamma and tumor necrosis factor-alpha gene transfer. Cancer Gene Ther. (2002) 9(11):925-934.
   PubMed Web of Science ®Google Scholar
• ROTH W, ISENMANN S, NAUMANN U et al.: Locoregional Apo2L/TRAIL Eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity. Biochem. Biophys. Res. Commun. (1999) 265(2):479-483.
   PubMed Web of Science ®Google Scholar
• ASHKENAZI A, PAI RC, FONG S et al.: Safety and antitumor activity of recombinant soluble Apo2 ligand. J. Clin. Invest. (1999) 104(2):155-162.
   PubMed Web of Science ®Google Scholar
• ABOODY KS, NAJBAUER J, SCHMIDT NO et al.: Targeting of melanoma brain metastases using engineered neural stem/progenitor cells. Neurooncol. (2006) 8(2):119-126.
   Google Scholar
• LEE J, HAMPL M, ALBERT P, FINE HA: Antitumor activity and prolonged expression from a TRAIL-expressing adenoviral vector. Neoplasia (2002) 4(4):312-323.
   PubMed Web of Science ®Google Scholar
• LIU Y, EHTESHAM M, SAMOTO K et al.: In situ adenoviral interleukin 12 gene transfer confers potent and long-lasting cytotoxic immunity in glioma. Cancer Gene Ther. (2002) 9(1):9-15.
   PubMed Web of Science ®Google Scholar
• HU J, YUAN X, BELLADONNA ML et al.: Induction of potent antitumor immunity by intratumoral injection of IL-23 transduced dendritic cells. Cancer Res. (2006) 66(17):8887-8896.
   PubMed Web of Science ®Google Scholar
• RUBIO D, GARCIA-CASTRO J, MARTIN MC et al.: Spontaneous human adult stem cell transformation. Cancer Res. (2005) 65(8):3035-3039.
   PubMed Web of Science ®Google Scholar